Internal Medicine, Nephrology · Bakersfield, CA
NPI
1720087877
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
3933 Coffee Rd, Suite A
Bakersfield, CA, 93308
Phone (661) 588-9999
Groups this clinician bills Medicare through
Medicare paid, 2024
$282K
2,269 services
Medicare patients, 2024
675
Average age 69
Drug cost, 2024
$1.6M
3,732 prescriptions
Company payments, 2025
$1,816
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sudhir S Joshi was code 99214 (office e&m - established), 561 times for 271 patients. In total Sudhir S Joshi billed 2,269 services in 17 codes, and Medicare paid $282K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 561 | 271 | $95.62 | $54K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 555 | 276 | $12.91 | $7,167 |
| 90960 ESRD Related Services (not dialysis) | Office | 479 | 218 | $278.66 | $133K |
| 99223 Hospital E&M - Initial | Facility | 164 | 140 | $137.60 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 116 | 77 | $62.55 | $7,256 |
| 99204 Office E&M - New | Office | 88 | 88 | $123.98 | $11K |
| 90961 ESRD Related Services (not dialysis) | Office | 84 | 62 | $234.49 | $20K |
| 90966 ESRD Related Services (not dialysis) | Office | 70 | 12 | $232.89 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 61 | 50 | $93.06 | $5,677 |
| 90935 Hemodialysis | Facility | 17 | 16 | $56.19 | $955 |
| 90935 Hemodialysis | Office | 13 | 11 | $56.32 | $732 |
By year: 2022 $249K for 1,896 services; 2023 $279K for 1,925 services; 2024 $282K for 2,269 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sudhir S Joshi prescribed most often to Medicare patients was Calcitriol, with 353 prescriptions and refills. In total Sudhir S Joshi wrote 3,732 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 353 | 711 | 87 | $2,755 |
| Veltassa Patiromer Calcium Sorbitex | 204 | 241 | 53 | $182K |
| Amlodipine Besylate Generic | 175 | 428 | 66 | $430 |
| Furosemide Generic | 170 | 356 | 50 | $665 |
| Hydralazine Hcl Generic | 134 | 264 | 43 | $1,374 |
| Calcium Acetate Generic | 131 | 184 | 35 | $9,951 |
| Prosol Parenteral Amino Acid 20% No.1 | 128 | 128 | Under 11 | $22K |
| Clonidine Hcl Generic | 126 | 226 | 41 | $1,007 |
| Atenolol Generic | 126 | 322 | 44 | $630 |
| Sevelamer Carbonate Generic | 121 | 154 | 28 | $23K |
| Losartan Potassium Generic | 104 | 222 | 37 | $555 |
| Lokelma Sodium Zirconium Cyclosilicate | 101 | 116 | 28 | $96K |
| Rayaldee Calcifediol | 86 | 92 | 24 | $93K |
| Procrit Epoetin Alfa | 71 | 73 | 18 | $70K |
| Velphoro Sucroferric Oxyhydroxide | 69 | 100 | 21 | $195K |
Brand drugs: - claims; generic drugs: 2,773 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sudhir S Joshi $1,816 ($1,816 in general payments such as food, travel and fees) from 26 companies. The largest payer was Ardelyx, Inc. with $389.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 16 | $389 |
| ANI Pharmaceuticals, Inc. ANIP | 11 | $267 |
| Abbvie Inc. ABBV | 1 | $125 |
| Amgen Inc. AMGN | 6 | $117 |
| Abiomed JNJ | 3 | $105 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $74.02 |
| Mallinckrodt Hospital Products Inc. | 2 | $72.79 |
| Vifor Pharma, Inc. | 2 | $57.83 |
| Akebia Therapeutics Inc AKBA | 2 | $52.02 |
| GlaxoSmithKline, LLC. GSK | 2 | $51.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.